Ted M T van Hinsbergh1, Stephanie C M de Crom2, Robert Lindeboom3, Marceline A M van Furth4, Charlie C Obihara5. 1. Department of Pediatrics, Elisabeth-Tweesteden Hospital, Hilvarenbeekseweg 60, 5022 LC, Tilburg, the Netherlands. t.vanhinsbergh@etz.nl. 2. Department of Pediatric, Bravis Hospital, Boerhaaveplein 1, 4624 VT, Bergen op Zoom, the Netherlands. 3. Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam UMC, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands. 4. Department of Pediatric Infectious Diseases and Immunology, Amsterdam UMC, Vrije Universiteit Amsterdam, AI&II, De Boelelaan 1117, 1081 HV, Amsterdam, the Netherlands. 5. Department of Pediatrics, Elisabeth-Tweesteden Hospital, Hilvarenbeekseweg 60, 5022 LC, Tilburg, the Netherlands.
Abstract
This multicenter prospective cohort study describes the impact of human parechovirus meningitis on gross-motor neurodevelopment of young children. Gross-motor function was measured using Alberta Infant Motor Scale. Of a total of 38 eligible children < 10 months of age at onset, nine cases had clinical evidence of meningitis and polymerase chain reaction positive for human parechovirus in cerebrospinal fluid; 11 had no meningitis and polymerase chain reaction positive for human parechovirus in nasopharyngeal aspirate, blood, urine, or feces; and in 18, no pathogen was identified (reference group).The children with human parechovirus meningitis showed more frequent albeit not statistically significant suspect gross-motor function delay (mean Z-score (standard deviation) - 1.69 (1.05)) than children with human parechovirus infection-elsewhere (- 1.38 (1.51)). The reference group did not fall in the range of suspect gross-motor function delay (- 0.96 (1.07)). Adjustment for age at onset and maternal education did not alter the results. Conclusion: Six months after infection, children with human parechovirus meningitis showed more frequent albeit not statistically significant suspect gross-motor function delay compared to the population norm and other two groups. Longitudinal studies in larger samples and longer follow-up periods are needed to confirm the impact and persistence of human parechovirus meningitis on neurodevelopment in young children. What is Known: • Human parechovirus is progressively becoming a major viral cause of meningitis in children. • There is keen interest in the development of affected infants with human parechovirus meningitis. What is New: • This study describes prospectively gross-motor functional delay in children with both clinical evidence of meningitis and polymerase chain reaction positive for human parechovirus in cerebrospinal fluid. • It shows the importance of screening young children for developmental delay in order to refer those with delay for early intervention to maximize their developmental potential.
This multicenter prospective cohort study describes the impact of human parechovirus meningitis on gross-motor neurodevelopment of young children. Gross-motor function was measured using Alberta Infant Motor Scale. Of a total of 38 eligible children < 10 months of age at onset, nine cases had clinical evidence of meningitis and polymerase chain reaction positive for human parechovirus in cerebrospinal fluid; 11 had no meningitis and polymerase chain reaction positive for human parechovirus in nasopharyngeal aspirate, blood, urine, or feces; and in 18, no pathogen was identified (reference group).The children with human parechovirus meningitis showed more frequent albeit not statistically significant suspect gross-motor function delay (mean Z-score (standard deviation) - 1.69 (1.05)) than children with human parechovirus infection-elsewhere (- 1.38 (1.51)). The reference group did not fall in the range of suspect gross-motor function delay (- 0.96 (1.07)). Adjustment for age at onset and maternal education did not alter the results. Conclusion: Six months after infection, children with human parechovirus meningitis showed more frequent albeit not statistically significant suspect gross-motor function delay compared to the population norm and other two groups. Longitudinal studies in larger samples and longer follow-up periods are needed to confirm the impact and persistence of human parechovirus meningitis on neurodevelopment in young children. What is Known: • Human parechovirus is progressively becoming a major viral cause of meningitis in children. • There is keen interest in the development of affected infants with human parechovirus meningitis. What is New: • This study describes prospectively gross-motor functional delay in children with both clinical evidence of meningitis and polymerase chain reaction positive for human parechovirus in cerebrospinal fluid. • It shows the importance of screening young children for developmental delay in order to refer those with delay for early intervention to maximize their developmental potential.
Entities:
Keywords:
Children; Human parechovirus; Meningitis; Neurodevelopment
Authors: H Harvala; J Calvert; D Van Nguyen; L Clasper; N Gadsby; P Molyneaux; K Templeton; C McWilliams Leitch; P Simmonds Journal: Euro Surveill Date: 2014-04-17
Authors: Mylene C Berk; Andrea H L Bruning; Aleid G van Wassenaer-Leemhuis; Katja C Wolthers; Dasja Pajkrt Journal: Pediatr Infect Dis J Date: 2018-10 Impact factor: 2.129
Authors: María Cabrerizo; María Díaz-Cerio; Carmen Muñoz-Almagro; Núria Rabella; David Tarragó; María Pilar Romero; María José Pena; Cristina Calvo; Sonia Rey-Cao; Antonio Moreno-Docón; Inés Martínez-Rienda; Almudena Otero; Gloria Trallero Journal: J Med Virol Date: 2016-08-22 Impact factor: 2.327
Authors: Brenda M Westerhuis; Gerrit Koen; Joanne G Wildenbeest; Dasja Pajkrt; Menno D de Jong; Kimberley S M Benschop; Katja C Wolthers Journal: J Gen Virol Date: 2012-07-25 Impact factor: 3.891
Authors: Philip N Britton; Russell C Dale; Michael D Nissen; Nigel Crawford; Elizabeth Elliott; Kristine Macartney; Gulam Khandaker; Robert Booy; Cheryl A Jones Journal: Pediatrics Date: 2016-01-20 Impact factor: 7.124
Authors: S C M de Crom; C C Obihara; R A de Moor; E J M Veldkamp; A M van Furth; J W A Rossen Journal: J Clin Virol Date: 2013-08-21 Impact factor: 3.168